BAT delivered similar results in 2020 to the previous year despite the pandemic and a slip in its heated tobacco portfolio – boosted by growth in its oral tobacco products in the second half of the year ...
Are you already a subscriber? login here
Are you already a subscriber? login here
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.